Hemi-Gland Cryoablation for Prostate Cancer at UCLA
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/22/2018 |
| Start Date: | September 15, 2017 |
| End Date: | December 31, 2020 |
Cryoablation: An Observational Study of Hemi-Gland Cryoablation Outcomes for Prostate Cancer at UCLA
This is a prospective data collection of men who are electing to undergo prostate hemi-gland
cryoablation.
The purpose of this observational research study is to investigate the localized treatment of
prostate cancer using hemi-gland cryoablation.
UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior
research because all patients at UCLA have had a pre-treatment multi-parametric MRI and
Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results
in more precise assessment of a target region of cancer for ablation which may, in turn,
result in improved clinical outcomes.
cryoablation.
The purpose of this observational research study is to investigate the localized treatment of
prostate cancer using hemi-gland cryoablation.
UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior
research because all patients at UCLA have had a pre-treatment multi-parametric MRI and
Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results
in more precise assessment of a target region of cancer for ablation which may, in turn,
result in improved clinical outcomes.
Inclusion Criteria:
- Patient has undergone or has elected to undergo hemi-gland cryoablation at UCLA from a
start date of 1/1/2017 to an end date of 12/31/2018
- Low or intermediate risk prostate cancer (Gleason ≤ 7) or select high-risk patients
(Gleason 8 prostate cancer on no more than 2 biopsy cores and maximum cancer core
lengths on biopsy of ≤ 8 mm).
- PSA ≤ 20
- Prostate volume of ≤ 70 cc
- Ability to complete informed consent form
Exclusion Criteria:
- Prior treatment for prostate cancer (with the exception of androgen deprivation
therapy)
- Medical contraindication to follow-up mpMRI or prostate biopsy
- Patients unable to tolerate general or regional anesthesia.
- Positive bone scan (if done or clinically indicated).
We found this trial at
1
site
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
Click here to add this to my saved trials
